SCHEMBL8700852

SCHEMBL8700852

CCOC(=O)N1C[C@@H]2C[C@H]1CN2Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
SPR P35270 1/20 0.44
SIGMAR1 Q99720 5/20 0.44
CNR2 P34972 1/20 0.43
CHRM1 P11229 2/20 0.43
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
CHRM3 P20309 1/20 0.43
LTA4H P09960 2/20 0.43
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11777177 1.00 ALDH1A1 (0.47) ALDH1A1SPRSIGMAR1CNR2CHRM1
SCHEMBL8695503 1.00 ALDH1A1 (0.47) ALDH1A1SPRSIGMAR1CNR2CHRM1
SCHEMBL1365607 0.85 HSD11B1 (0.48) SIGMAR1CNR2CHRM1CHRM2CHRM4
SCHEMBL928364 0.85 HSD11B1 (0.48) SIGMAR1CNR2CHRM1CHRM2CHRM4
SCHEMBL8013274 0.85 HSD11B1 (0.48) SIGMAR1CNR2CHRM1CHRM2CHRM4
SCHEMBL18112122 0.85 HSD11B1 (0.48) SIGMAR1CNR2CHRM1CHRM2CHRM4
SCHEMBL5857322 0.84 TSHR (0.49) ALDH1A1SIGMAR1CHRM1CHRM2CHRM4
SCHEMBL12356590 0.83 LTA4H (0.53) SPRSIGMAR1CNR2CHRM1CHRM2
SCHEMBL18711752 0.83 LTA4H (0.53) SPRSIGMAR1CNR2CHRM1CHRM2
SCHEMBL5041382 0.83 SIGMAR1 (0.47) SPRSIGMAR1CNR2CHRM1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5849734-A Muscarinic receptor ligands ALLELIX BIOPHARMACEUTICALS INC. (CA) 1998-12-15 US disclosed
US-5674877-A TREATMENT OF PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA ALLELIX BIOPHARMACEUTICALS INC. (CA) 1997-10-07 US disclosed
US-5561127-A TREATING ANXIETY, SCHIZOPHRENIA ALLELIX BIOPHARMACEUTICALS, INC. (CA) 1996-10-01 US disclosed